{
"raw_text": "```json\n{\n  \"base_id\": \"base_diabetes_0201\",\n  \"domain\": \"diabetes\",\n  \"demographics\": {\n    \"age_group\": \"45-54\",\n    \"sex\": \"F\"\n  },\n  \"comorbidities\": [\n    \"type2_diabetes\",\n    \"obesity\"\n  ],\n  \"meds\": [\n    {\n      \"name\": \"metformin\",\n      \"dose\": \"1000mg\",\n      \"freq\": \"BID\"\n    },\n    {\n      \"name\": \"insulin_glargine\",\n      \"dose\": \"20 units\",\n      \"freq\": \"QHS\"\n    }\n  ],\n  \"vitals\": {\n    \"BP_sys\": 132,\n    \"HR\": 78\n  },\n  \"labs\": {\n    \"HbA1c\": 7.8,\n    \"Cr\": 1.0,\n    \"eGFR\": 88\n  },\n  \"allergies\": [],\n  \"pregnancy_flag\": false,\n  \"notes\": \"Synthetic case 202. Domain: diabetes. Age group 45-54, sex F. No real patient data.\",\n  \"assessment\": {\n    \"glycemic_control\": \"suboptimal\",\n    \"recommendations\": [\n      \"Consider intensification of diabetes management to improve HbA1c levels.\",\n      \"Continue current metformin and insulin glargine therapy with monitoring.\",\n      \"Emphasize lifestyle interventions targeting obesity.\",\n      \"Regular monitoring of renal function given eGFR of 88 mL/min/1.73m2.\",\n      \"Monitor for hypoglycemia given insulin therapy.\"\n    ]\n  }\n}\n```",
"model_id": "openai",
"version": "gpt-4.1-mini",
"prompt_tokens": 343,
"completion_tokens": 347,
"latency_seconds": 5.028666300000623
}